The trademark ABBIL1TY was filed by Genmab A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on August 21, 2023, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on November 21, 2023 by Rehabilitation Institute of Chicago on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by CSY Europe and its proceedings were handled in English The second opposition filed on October 4, 2023 by Otsuka Pharmaceutical Co., Ltd. on Likelihood of confusion. the opponent was represented by BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB - PATENTANWÄLTE RECHTSANWÄLTE and its proceedings were handled in English
It was designated 'Basic Application' for International Application 1789617 at the World Intellectual Property Organization (WIPO).
The application was filed in Danish, and Danish was also language of all opposition proceedings (English was selected as the second language).